Full-Time

Business Development Representative

Confirmed live in the last 24 hours

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Healthcare

Compensation Overview

$135kAnnually

Mid, Senior

Long Island, New York, USA

Expect approximately 20-25% travel from a home office.

Category
Business Development
Business & Strategy
Required Skills
Sales
Requirements
  • Proven sales skills and track-record of sales achievement
  • Account development - Experience building and supporting strong clinical programs is preferred.
  • Clinical / technical proficiency - Quick learner able to grasp new clinical/technical information and then disseminate to customers.
  • Develop relationships with key account stakeholders, to include admin, admin support, key cardiologists, key referring physician practices, hospital marketing and key strategic personnel to drive awareness of a cCTA/FFRct pathway, broaden HeartFlow referrals, and deepen HeartFlow adoption.
  • Work in a cross functional capacity to coordinate field and HQ resources needed to support focused customers and execute program development plans, support sales, marketing, education and training.
  • Customer-focused mentality.
  • Ability to explain medical technologies to referring physicians and health care professionals.
  • Knowledge of cardiac patient pathways and diagnostic technology is preferred.
  • Self-motivated and ability to initiate, organize, and complete projects.
  • Excellent problem-solving ability, especially under pressure.
  • Extremely strong work ethic.
  • Works well in a cross-functional team environment.
  • Ability to work effectively with customers from a wide range of technical and clinical backgrounds.
  • Excellent verbal and written communication skills. Professional etiquette.
  • Experience with Salesforce.com or similar CRM.
  • 4-year degree with 5+years of related sales or clinical experience or 2-year degree with 7+ years related sales or clinical experience.
  • Degree in Science, Medical, Business, Marketing or Technical field is preferred.
  • Prior experience in medical device, cardiology pharmaceuticals, cardiology radio-pharmaceuticals, hospital, or medical software is highly desired.
  • Experience with introducing new cardiovascular technologies into hospitals is highly desired.
Responsibilities
  • Will work with key strategic HeartFlow accounts to drive growth and adoption of a cCTA and FFRct clinical pathway. In these accounts, the BDR will develop and execute business development plans working closely with the account’s key stakeholders
  • Facilitate cross-functional collaboration throughout the organization. Tools for program development could include key deployment of HeartFlow internal leadership and physician mentors, organizing and staffing of dinner programs, VIP Visits, organizing HeartFlow CT Pathway road-shows, referring physician office meetings, etc. This role will work closely with the other HeartFlow team members to include respective DSM, Marketing, Market Access, CT Apps, Product Development and Clinical
  • Increase HeartFlow usage within the designated key strategic HeartFlow account by: 1) Maintaining and building relationships with referring physicians and other key clinical stakeholders 2) Educating customers on HeartFlow’s value proposition by giving presentations / having discussions with referring MDs 3) Promoting / championing HeartFlow and building advocacy
  • Production/Success/Achievement of the Business Development Representative will be evaluated and based on performance in active/targeted accounts(metrics): 1) Meet / exceed quota for the strategic HeartFlow account (within existing customer locations) 2) cCTA growth (conversion of non-invasive tests) and FFRct penetration / case growth over baseline (% and $) in assigned accounts.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company's product offerings include the HeartFlow Analysis, which encompasses various analyses like FFRCT, RoadMap, Plaque, and HeartFlow Planner, all of which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. HeartFlow differentiates itself from competitors by focusing on non-invasive solutions that enhance treatment planning. The company's goal is to improve cardiovascular care by providing tools that make diagnosis and treatment safer and more efficient.

Company Stage

Series F

Total Funding

$858.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

15%

2 year growth

18%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for AI-enabled diagnostic tools aligns with HeartFlow's solutions.
  • The non-invasive cardiac imaging market is projected to grow at a 7.5% CAGR until 2028.
  • Recent $215 million funding supports HeartFlow's commercial scale and product advancement.

What critics are saying

  • Emerging AI-driven competitors could threaten HeartFlow's market share.
  • Algorithmic bias in AI technology may affect diagnostic accuracy and patient outcomes.
  • High costs may limit adoption in cost-sensitive healthcare markets, affecting revenue growth.

What makes HeartFlow unique

  • HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
  • Their AI-enabled technology provides non-invasive, personalized 3D heart models for precise diagnosis.
  • HeartFlow's products are FDA-cleared and commercially available in major global markets.

Help us improve and share your feedback! Did you find this helpful?